STOCK-BASED COMPENSATION (Tables)

12 Months Ended

May 25, 2025

Share-Based Payment Arrangement [Abstract]

Schedule of Recognized Stock-Based Compensation Expense

Stock-based compensation expense included in continuing operations was as follows:  

	Fiscal Year Ended
(in millions)	May 25, 2025		May 26, 2024		May 28, 2023
Stock options	$	7.5	$	6.8	$	6.3
Restricted stock units	9.8		8.6		7.4
Darden stock units	37.3		31.9		34.8
Equity-settled performance-based restricted stock units	19.4		16.1		14.3
Employee stock purchase plan	3.2		3.0		2.8
Director compensation program/other	1.9		2.1		1.9
Total	$	79.1	$	68.5	$	67.5

Excess income tax benefits related to the exercise of stock options and vesting of other equity-settled stock-based compensation recognized in income tax expense from continuing operations was as follows:  

	Fiscal Year Ended
(in millions)	May 25, 2025		May 26, 2024		May 28, 2023
Income tax benefits	$	11.8	$	12.7	$	6.5

Schedule of Weighted-Average Fair Value and Related Assumptions for Stock-Based Compensation

The weighted-average fair value of non-qualified stock options and the related assumptions used in the Black-Scholes model to record stock-based compensation are as follows:

	Granted in Fiscal Year Ended
	May 25, 2025			May 26, 2024			May 28, 2023
Weighted-average fair value	$	44.79		$	55.56		$	36.20
Dividend yield	3.6		%	3.4		%	3.8		%
Expected volatility of stock	40.8		%	42.2		%	42.0		%
Risk-free interest rate	4.1		%	4.0		%	2.8		%
Expected option life (in years)	6.3			5.9			5.9
Weighted-average exercise price per share	$	139.43		$	169.02		$	121.47

The weighted-average grant date fair value of equity-settled PRSUs and the related assumptions used in the Monte Carlo simulation to record stock-based compensation are as follows:

	Granted in Fiscal Year Ended
	May 25, 2025			May 26, 2024			May 28, 2023
Dividend yield (1)	0.0		%	0.0		%	0.0		%
Expected volatility of stock	26.5		%	32.3		%	55.5		%
Risk-free interest rate	4.2		%	4.5		%	2.9		%
Expected option life (in years)	2.9			2.9			2.8
Weighted-average grant date fair value per unit	$	181.65		$	217.11		$	137.73

(1)Assumes a reinvestment of dividends.

Schedule of Stock Option Activity

The following table presents a summary of our stock option activity as of and for the year ended May 25, 2025:

	Options (in millions)	Weighted-Average Exercise Price Per Share	Weighted-Average Remaining Contractual Life (Yrs)	Aggregate Intrinsic Value (in millions)
Outstanding beginning of period	1.34	$111.08	5.68	$51.6
Options granted	0.17	139.43
Options exercised	(0.48)	90.10
Options canceled	—	—
Outstanding end of period	1.03	$125.30	6.16	$80.9
Exercisable	0.51	$108.75	4.41	$49.0

Schedule of Restricted Stock and RSU Activity

The following table presents a summary of our RSU activity as of and for the fiscal year ended May 25, 2025:

	Shares (in millions)	Weighted-Average Grant Date Fair Value Per Share
Outstanding beginning of period	0.26	$132.38
Shares granted	0.08	148.94
Shares vested	(0.07)	136.62
Shares canceled	(0.01)	158.78
Outstanding end of period	0.26	$135.67

Schedule of Darden Stock Unit Activity

The following table presents a summary of our Darden stock unit activity as of and for the fiscal year ended May 25, 2025:

(All units settled in cash)	Units (in millions)	Weighted-Average Fair Value Per Unit
Outstanding beginning of period	0.76	$147.60
Units granted	0.20	145.03
Units vested	(0.29)	149.87
Units canceled	(0.03)	139.35
Outstanding end of period	0.64	$204.02

Schedule of Performance Stock Unit Activity

The following table presents a summary of our equity-settled PRSU activity as of and for the fiscal year ended May 25, 2025:

	Units (in millions)	Weighted-Average Grant Date Fair Value Per Unit
Outstanding beginning of period	0.35	$152.39
Units granted	0.11	181.65
Units granted/canceled performance impact	0.02	158.40
Units vested	(0.15)	126.63
Units canceled	—	—
Outstanding end of period	0.33	$175.95